Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Hospital Universitario La Paz
Sponsor

Hospital Universitario La Paz

Spain Paseo De La Castellana 261, 28046 Madrid, Spain

About the sponsor

Clinical research in acute ischemic stroke focuses on mechanical thrombectomy, procedural sedation, and the organisation of time to revascularization in emergency treatment pathways.

  • Endovascular stroke treatment
  • High-flow nasal cannula support
  • General anesthesia

These studies address peri-procedural management in neurovascular intervention and hospital-based stroke logistics.

About Specializations

Hospital Universitario La Paz runs clinical trials in conditions such as Sarcoma, Analgesic therapy, Chronic kidney disease, Critical illness, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

15 clinical trials

Chronic kidney disease

Recruiting

Study on Tacrolimus and Sirolimus for Kidney Transplant Patients at High Risk of Cytomegalovirus Infection

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Mycophenolic Acid
  • Sponsor:Hospital Universitario La Paz

Critical illness

Recruiting

Study Comparing Isoflurane and Propofol for Sedation in Critically Ill Patients on Mechanical Ventilation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Isoflurane
  • Sponsor:Hospital Universitario La Paz

Ischaemic stroke

Recruiting

Comparison of General Anesthesia versus High-Flow Nasal Cannula Sedation in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fentanyl Citrate
  • Sponsor:Hospital Universitario La Paz

Sarcoma

Recruiting

Study on CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Advanced Sarcoma

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:CART45RA-NKG2D cells
  • Sponsor:Hospital Universitario La Paz

Sarcoma

Recruiting

Study of Activated NK Cells for Treating Sarcomas in Children, Adolescents, and Young Adults

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allogeneic Peripheral Blood-Derived Cd56+ Natural Killer Cells, Co-Cultured With K562-Mb15-41Bbi Cell Line
  • Sponsor:Hospital Universitario La Paz

Bladder transitional cell carcinoma

Recruiting

Study on Bladder Cancer: Testing Cisplatin and Drug Combination for Patients with Non-Muscle Invasive Bladder Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Hospital Universitario La Paz

Artificial insemination+1

Recruiting

Study on Pregnancy Rates in Women with Polycystic Ovary Syndrome Using Letrozole and Gonadotropins

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Hospital Universitario La Paz

Analgesic therapy

Recruiting

Study on Pain Relief Using Levobupivacaine Hydrochloride for Patients Undergoing Laparoscopic Colorectal Surgery

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Levobupivacaine Hydrochloride
  • Sponsor:Hospital Universitario La Paz

Haemodynamic instability

Recruiting

Finding the Right Dose of Dobutamine for Very Preterm Infants with Heart and Blood Flow Issues

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Dobutamine
  • Sponsor:Hospital Universitario La Paz

Dermatitis atopic

Recruiting

Study on Atopic Dermatitis Treatment with Baricitinib, Tralokinumab, Abrocitinib, Upadacitinib, and Dupilumab for Patients Needing Second-Line Systemic Therapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Abrocitinib
  • Sponsor:Hospital Universitario La Paz

Central nervous system neoplasm

Not yet recruiting

Safety of autologous NK cells with IL‑15 and CD45RA‑negative T cells with NKG2D CAR in children, adolescents and young adults with high‑grade brain tumors

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Sponsor:Hospital Universitario La Paz

Abdominal operation

Not yet recruiting

A study to evaluate the use of botulinum toxin type A - haemagglutinin complex to help close the abdomen in patients with an open abdomen.

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Hospital Universitario La Paz

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.